For profitable companies, the R&D credit is one of the most valuable offsets in the code, a direct reduction of federal income tax, not just a deduction. And what you can’t use this year doesn’t disappear.
Request a Complimentary AssessmentA deduction lowers the income you’re taxed on. A credit lowers the tax itself. The R&D credit offsets your federal income tax liability dollar-for-dollar, which makes it far more valuable than a deduction of the same size, often the difference between a nice-to-have and a material change in what you owe.
The R&D credit is part of the general business credit (§38). It can offset your income tax down to a floor, generally the greater of your tentative minimum tax or 25% of net regular tax liability above $25,000, so it won’t always zero out a single year’s liability. Whatever you can’t use isn’t lost; it carries.
Unused R&D credits carry back one year and forward up to twenty. Eligible small businesses, generally those with $50 million or less in average gross receipts over the prior three years, can also apply the credit against the alternative minimum tax, a meaningful benefit for profitable owners who would otherwise be limited by AMT.
The credit can be computed two ways, and the better answer depends on your history.
Claiming the credit ordinarily requires reducing your research deduction by the credit amount, unless you make the §280C election to take a reduced credit (the credit net of the top corporate rate, currently × 0.79) and keep the full deduction. With research expensing restored under §174A, that interplay matters, and we model it both ways so the deduction and credit work together rather than against each other.
A profitable manufacturer with $2.5M in qualified research expenses and a normal base computes an R&D credit of roughly:
Applied dollar-for-dollar against this year’s federal income tax, with any excess carried forward, and the §280C election modeled to preserve the research deduction.
Not always in a single year, because of the general business credit floor. But unused credit carries back one year and forward up to twenty, so it isn’t lost, it’s deferred.
They’re two ways to compute the same credit off different bases. Companies without clean 1980s-era base data usually favor the ASC; others do better under the regular method. We run both.
Often, yes, especially now that research is expensed under §174A. We model the reduced-credit election against the full-credit-and-reduced-deduction alternative and use whichever leaves you better off.
Yes. Many states offer their own credit on top of the federal one; we handle both in a single engagement.
This page is general information, not tax or legal advice. Eligibility and amounts depend on the taxpayer’s facts and applicable law, and are determined through the appropriate R&D study. Novaric does not guarantee eligibility, credit amounts, or any IRS outcome.